Equities Research Analysts’ price target changes for Tuesday, December 31st:
Arqit Quantum (NASDAQ:ARQQ) had its price target boosted by HC Wainwright from $27.00 to $52.00. HC Wainwright currently has a buy rating on the stock.
Axsome Therapeutics (NASDAQ:AXSM) had its target price trimmed by Mizuho from $124.00 to $122.00. The firm currently has an outperform rating on the stock.
FTAI Aviation (NYSE:FTAI) had its price target raised by Stifel Nicolaus from $156.00 to $167.00. Stifel Nicolaus currently has a buy rating on the stock.
FTAI Aviation (NYSE:FTAI) had its price target raised by BTIG Research from $180.00 to $190.00. BTIG Research currently has a buy rating on the stock.
Glaukos (NYSE:GKOS) had its target price raised by Stifel Nicolaus from $153.00 to $175.00. They currently have a buy rating on the stock.
Chart Industries (NYSE:GTLS) had its target price boosted by Stifel Nicolaus from $200.00 to $231.00. Stifel Nicolaus currently has a buy rating on the stock.
Harley-Davidson (NYSE:HOG) had its price target lowered by Robert W. Baird from $40.00 to $36.00. The firm currently has a neutral rating on the stock.
Merit Medical Systems (NASDAQ:MMSI) had its target price increased by Raymond James from $105.00 to $110.00. They currently have an outperform rating on the stock.
Palo Alto Networks (NASDAQ:PANW) had its price target reduced by Evercore ISI from $455.00 to $230.00. They currently have an outperform rating on the stock.
Pinnacle Financial Partners (NASDAQ:PNFP) had its price target raised by Citigroup Inc. from $123.00 to $132.00. Citigroup Inc. currently has a buy rating on the stock.
Sangamo Therapeutics (NASDAQ:SGMO) had its target price cut by Wells Fargo & Company from $3.00 to $2.00. They currently have an equal weight rating on the stock.
Valley National Bancorp (NASDAQ:VLY) had its price target cut by Citigroup Inc. from $10.50 to $10.00. Citigroup Inc. currently has a neutral rating on the stock.
Verastem (NASDAQ:VSTM) had its price target increased by BTIG Research from $13.00 to $20.00. The firm currently has a buy rating on the stock.
Receive News & Ratings for Arqit Quantum Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arqit Quantum Inc and related companies with MarketBeat.com's FREE daily email newsletter.
